CIRM Manufacturing Network Symposium attendees. The California Institute for Regenerative Medicine (CIRM) is driving conversations and collaboration to address the manufacturing challenges of cell and gene therapies (CGT). CIRM hosted its inaugural Manufacturing Network Symposium in South San Francisco, bringing together more than 100 experts and stakeholders from the regenerative medicine field, including scientific leaders … Continue reading Tackling Cell and Gene Therapy Manufacturing Challenges
Cell Therapy
A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation
At the California Institute for Regenerative Medicine (CIRM), we highlight achievements from the research we support. We recently spoke with Cory Nicholas, PhD, CEO and Co‑Founder of Neurona Therapeutics, about a major milestone for the clinical‑stage company. Neurona received the FDA’s Regenerative Medicine Advanced Therapy (RMAT) designation for NRTX‑1001, a CIRM‑funded neural cell therapy for … Continue reading A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation
CIRM team shines at ASGCT annual meeting in sunny Los Angeles
The California Institute for Regenerative Medicine (CIRM) team spent a week in sunny Los Angeles spreading awareness of its mission at the American Society of Gene & Cell Therapy (ASGCT) annual meeting. The meeting provides a place for people in the cell and gene therapy field to learn from the latest scientific research, stay up … Continue reading CIRM team shines at ASGCT annual meeting in sunny Los Angeles
Stem cells help researchers create genetic blueprint for glaucoma
Scientists are using stem cells to create a detailed genetic blueprint of glaucoma, offering a powerful new way to study and target the disease. Leading cause of blindness Glaucoma is the world’s leading cause of irreversible blindness. Current treatments only slow its progression, and researchers have long lacked safe ways to study the retinal ganglion … Continue reading Stem cells help researchers create genetic blueprint for glaucoma
Overcoming obstacles and advancing treatments to patients
UC Davis GMP Manufacturing facility: Photo courtesy UC Davis When you try something that has never been done before, you are bound to face challenges and obstacles. At the California Institute for Regenerative Medicine (CIRM) we are used to coming up with great ideas and hearing people ask “Well, how are you going to do … Continue reading Overcoming obstacles and advancing treatments to patients
U.C. San Diego Scientist Larry Goldstein Joins Stem Cell Agency’s Board
Larry Goldstein, PhD. Larry Goldstein PhD, has many titles, one of which sums up his career perfectly, “Distinguished Professor”. Dr. Goldstein has distinguished himself on many fronts, making him an ideal addition to the governing Board of the California Institute for Regenerative Medicine (CIRM). Dr. Goldstein – everyone calls him Larry - is a Cell … Continue reading U.C. San Diego Scientist Larry Goldstein Joins Stem Cell Agency’s Board
CIRM Board Approves Third Clinical Trial for COVID-19
Dr. Xiaokui Zhang (left), Dr. Albert Wong (center), and Dr. Preet Chaudhary (right) Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at Celularity to conduct a clinical trial for the treatment of COVID-19. This brings the total number of CIRM clinical trials to 64, including … Continue reading CIRM Board Approves Third Clinical Trial for COVID-19
Stem cells used to promote quick and precise bone healing
A close-up view of the intricate microarchitecture of the pluripotent stem-cell-derived extracellular matrix. Image Credit: Carl Gregory/Texas A&M Although some broken bones can be mended with the help of a cast, others require more complex treatments. Bone grafts, which can come from the patient's own body or a donor, are used to transplant bone tissue … Continue reading Stem cells used to promote quick and precise bone healing
Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
Dr. Jianhua Yu (left), Dr. Helen Blau (center), and Dr. Albert Wong (right) COVID‑19 targets many parts of the body, often with serious or life‑threatening effects. This past Friday, the CIRM Board approved investments in three early‑stage research projects that take new approaches to treating the virus. City of Hope Dr. Jianhua Yu at the … Continue reading Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
Two rare diseases, two pieces of good news
Dr. Stephanie Cherqui Last week saw a flurry of really encouraging reports from projects that CIRM has supported. We blogged about two of them last Wednesday, but here’s another two programs showing promising results. UC San Diego researcher Dr. Stephanie Cherqui is running a CIRM-funded clinical trial for cystinosis. This is a condition where patients … Continue reading Two rare diseases, two pieces of good news